# Effect of Sitagliptin on Endothelial Progenitor Cells

> **NCT00968006** · PHASE4 · COMPLETED · sponsor: **University of Padova** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT00968006
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968006, "Effect of Sitagliptin on Endothelial Progenitor Cells". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00968006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*